So a friend of mine just put me on to AERI. It's a company that makes treatments for glaucoma and other eye diseases.  Allegedly this one is supposed to double from its current lows to about $24 over the next few months.  This is likely because they have a couple of promising drugs undergoing trials. Use this quarterly report as the start of your DD:

investors.aeriepharma.com/node...